down arrow

Zenotech Lab.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE486F01012
  • NSEID:
  • BSEID: 532039
INR
63.50
4.25 (7.17%)
BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 7.94 k

Click here to access the older version
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

59.5963.90

52 Week

51.00107.79
Valuation
Technical
Day's Volume

CASH

7.94 k (-52.34%) Volume

Shareholding (Dec 2024)

FII

0.00%

Held by 0 FIIs

DII

0.99%

Held by 0 DIIs

Promoter

68.84%

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Dashboard
1

Poor long term growth as Net Sales has grown by an annual rate of 9.62% and Operating profit at 10.74% over the last 5 years

 
2

Flat results in Dec 24

3

Stock is technically in a Mildly Bearish range

4

With ROE of 4.2, it has a Very Expensive valuation with a 3.9 Price to Book Value

5

Consistent Underperformance against the benchmark over the last 3 years

stock-summaryMojo Parameters
Mojo Parameters
Loading Valuation Snapshot...
Stock DNA
stock-summary
Industry

Pharmaceuticals & Drugs

stock-summary
Market cap

INR 388 Cr (Micro Cap)

stock-summary
P/E

93.00

stock-summary
Industry P/E

33

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.24

stock-summary
Return on Equity

4.16%

stock-summary
Price to Book

3.88

Revenue and Profits (1 Year):
Net Sales:
10 Cr
(Quarterly Results - Dec 2024)
Net Profit:
2 Cr
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0%)
TimePeriod
Price Return
Dividend Return
Total Return
6 Months
-28.97%
0%
-28.97%
1 Year
-8.38%
0%
-8.38%
2 Years
26.75%
0%
26.75%
3 Years
11.7%
0%
11.7%
4 Years
63.45%
0%
63.45%
5 Years
238.67%
0%
238.67%

Zenotech Lab. for the last several years.

Risk Adjusted Returns v/s Sensex stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
9.62%
EBIT Growth (5y)
10.74%
EBIT to Interest (avg)
6.84
Debt to EBITDA (avg)
2.47
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
0.37
Tax Ratio
43.81%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0.99%
ROCE (avg)
-0.66%
ROE (avg)
15.91%
Valuation key factors
Factor
Value
P/E Ratio
93
Industry P/E
33
Price to Book Value
3.88
EV to EBIT
61.43
EV to EBITDA
27.17
EV to Capital Employed
4.77
EV to Sales
8.49
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
9.74%
ROE (Latest)
4.16%
Tecnicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Mildly Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
No Trend
Mildly Bearish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Dec 2024stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 0 Schemes

FIIs

Held by 0 FIIs

Promoter with highest holding

Sun Pharmaceutical Industries Limited (68.84%)

Highest Public shareholder

Padmasree Chigurupati (5.26%)

Individual Investors Holdings

22.83%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Standalone) - Dec'24 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Dec 2024 is 16.80% vs -1.57% in Sep 2024",
        "dir": 1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "QoQ Growth in quarter ended Dec 2024 is 25.19% vs 4.65% in Sep 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "10.22",
          "val2": "8.75",
          "chgp": "16.80%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "3.87",
          "val2": "2.41",
          "chgp": "60.58%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.62",
          "val2": "1.35",
          "chgp": "-54.07%",
          "chgp_class": "negative"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "1.69",
          "val2": "1.35",
          "chgp": "25.19%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "37.87%",
          "val2": "27.54%",
          "chgp": "10.33%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Standalone) - Sep'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": " Growth in half year ended Sep 2024 is -5.92% vs -9.07% in Sep 2023",
        "dir": 1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": " Growth in half year ended Sep 2024 is -38.32% vs -34.56% in Sep 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Sep'24",
        "Sep'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "17.64",
          "val2": "18.75",
          "chgp": "-5.92%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "5.84",
          "val2": "9.19",
          "chgp": "-36.45%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "1.35",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "2.64",
          "val2": "4.28",
          "chgp": "-38.32%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "33.11%",
          "val2": "49.01%",
          "chgp": "-15.90%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Standalone) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is -2.83% vs 0.95% in Dec 2023",
        "dir": -1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is -43.32% vs -3.54% in Dec 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "27.86",
          "val2": "28.67",
          "chgp": "-2.83%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "9.71",
          "val2": "14.45",
          "chgp": "-32.80%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "1.97",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "4.33",
          "val2": "7.64",
          "chgp": "-43.32%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "31.40%",
          "val2": "45.54%",
          "chgp": "-14.14%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Standalone) - Mar'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2024 is -4.15% vs 18.04% in Mar 2023",
        "dir": -1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2024 is -28.39% vs -47.75% in Mar 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'24",
        "Mar'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "36.76",
          "val2": "38.35",
          "chgp": "-4.15%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "17.22",
          "val2": "20.70",
          "chgp": "-16.81%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.11",
          "chgp": "-100.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "8.30",
          "val2": "11.59",
          "chgp": "-28.39%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "46.84%",
          "val2": "53.98%",
          "chgp": "-7.14%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Standalone) - Dec'24 - QoQstock-summary
Dec'24
Sep'24
Change(%)
Net Sales
10.22
8.75
16.80%
Operating Profit (PBDIT) excl Other Income
3.87
2.41
60.58%
Interest
0.00
0.00
Exceptional Items
0.62
1.35
-54.07%
Standalone Net Profit
1.69
1.35
25.19%
Operating Profit Margin (Excl OI)
37.87%
27.54%
10.33%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

QoQ Growth in quarter ended Dec 2024 is 16.80% vs -1.57% in Sep 2024

Direction Arrows
Standalone Net Profit

QoQ Growth in quarter ended Dec 2024 is 25.19% vs 4.65% in Sep 2024

All Quarterly Resultsstock-summary
Half Yearly Results Snapshot (Standalone) - Sep'24stock-summary
Sep'24
Sep'23
Change(%)
Net Sales
17.64
18.75
-5.92%
Operating Profit (PBDIT) excl Other Income
5.84
9.19
-36.45%
Interest
0.00
0.00
Exceptional Items
1.35
0.00
Standalone Net Profit
2.64
4.28
-38.32%
Operating Profit Margin (Excl OI)
33.11%
49.01%
-15.90%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

Growth in half year ended Sep 2024 is -5.92% vs -9.07% in Sep 2023

Direction Arrows
Standalone Net Profit

Growth in half year ended Sep 2024 is -38.32% vs -34.56% in Sep 2023

All Half Yearly Resultsstock-summary
Nine Monthly Results Snapshot (Standalone) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
27.86
28.67
-2.83%
Operating Profit (PBDIT) excl Other Income
9.71
14.45
-32.80%
Interest
0.00
0.00
Exceptional Items
1.97
0.00
Standalone Net Profit
4.33
7.64
-43.32%
Operating Profit Margin (Excl OI)
31.40%
45.54%
-14.14%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in nine months ended Dec 2024 is -2.83% vs 0.95% in Dec 2023

Direction Arrows
Standalone Net Profit

YoY Growth in nine months ended Dec 2024 is -43.32% vs -3.54% in Dec 2023

All Nine Monthly Resultsstock-summary
Annual Results Snapshot (Standalone) - Mar'24stock-summary
Mar'24
Mar'23
Change(%)
Net Sales
36.76
38.35
-4.15%
Operating Profit (PBDIT) excl Other Income
17.22
20.70
-16.81%
Interest
0.00
0.11
-100.00%
Exceptional Items
0.00
0.00
Standalone Net Profit
8.30
11.59
-28.39%
Operating Profit Margin (Excl OI)
46.84%
53.98%
-7.14%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2024 is -4.15% vs 18.04% in Mar 2023

Direction Arrows
Standalone Net Profit

YoY Growth in year ended Mar 2024 is -28.39% vs -47.75% in Mar 2023

All Annual Resultsstock-summary
stock-summaryCompany CV
About Zenotech Laboratories Ltd stock-summary
stock-summary
Zenotech Laboratories Ltd
Micro Cap
Pharmaceuticals & Drugs
Zenotech Laboratories Limited (Formerly Sunline Technologies Limited) was established in June, 1989 and changed to its present name effective on August 9, 2004. The Company is a pharmaceutical specialty generic injectables company engaged in the area of manufacturing biotechnology products. The Company's injectables product portfolio primarily serves niche therapy areas like oncology and anesthesiology.
Company Coordinates stock-summary
Company Details
S No 250-252 Turkapally Villag, Shameerpet Mandal RR District Hyderabad Telangana : 500078
stock-summary
Tel: 91-40-23480430/0435
stock-summary
http://www.zenotechlab.com
stock-summary
abdul.gafoor@zenotech.co.in
Registrar Details
Karvy Computershare Pvt Ltd, Plot No 17-24 , Near Image Hospital,, Reliance Cybervilae,Vithalrao Nagar,, Madhapur, Hyderabad
Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."